Product Categories
Country: | China |
---|---|
Tel: | 021-59167510 |
Mobile: | 18117107507 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Zenarestat | C17H11BrClFN2O4 | 112733-06-9 | Details |
AlexaFluor350NHSester | C16H14N2O9S | 200554-19-4 | Details |
Recilisib | C16H13ClO4S | 334969-03-8 | Details |
N-(tert-Butoxycarbonyl)-S-butylhomocysteine | C13H25NO4S | 1396969-20-2 | Details |
Alectinib Hydrochloride | C30H35ClN4O2 | 1256589-74-8 | Details |
(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid | C17H24N2O5 | 623950-02-7 | Details |
Afuresertib hydrochloride | C18H18Cl3FN4OS | 1047645-82-8 | Details |
(S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate | C28H36F3N3O5 | 868539-99-5 | Details |
Fmoc-Ala-OH | C18H17NO4 | 35661-39-3 | Details |
Glycyltyrosine dihydrate | C11H16N2O5 | 39630-46-1 | Details |
AC1-IN-1 | C18H18FN5O2 | 2762422-55-7 | Details |
5-Iodotubercidin | C11H13IN4O4 | 24386-93-4 | Details |
AKT-IN-6 | C22H20FN5O | 1430056-54-4 | Details |
Belizatinib | C33H44FN5O3 | 1357920-84-3 | Details |
Fmoc-Phe(4-I)-OH | C24H20INO4 | 82565-68-2 | Details |
JH-VIII-157-02 | C28H27N5O2 | 1639422-97-1 | Details |
GSK2110183 analog 1 hydrochloride | C18H17Cl3F2N4OS | 2070009-64-0 | Details |
Iruplinalkib | C29H38ClN6O2P | 1854943-32-0 | Details |
PI3K/Akt/mTOR-IN-2 | C17H13F2NO | 2757804-89-8 | Details |
Tolrestat | C16H14F3NO3S | 82964-04-3 | Details |
CH 223191 | C19H19N5O | 301326-22-7 | Details |
AT13148 | C17H16ClN3O | 1056901-62-2 | Details |
Afuresertib | C18H17Cl2FN4OS | 1047644-62-1 | Details |
Ipatasertib dihydrochloride | C24H33Cl2N5O2 | 1396257-94-5 | Details |
A-674563 hydrochloride | C22H23ClN4O | 2070009-66-2 | Details |
M2698 | C21H19ClF3N5O | 1379545-95-5 | Details |
Boc-D-Leucine monohydrate | C11H23NO5 | 200937-17-3 | Details |
Fipexide | C20H21ClN2O4 | 34161-24-5 | Details |
9-Cyclopentyladenine monomethanesulfonate | C11H17N5O3S | 189639-09-6 | Details |
Vevorisertib trihydrochloride | C35H39ClN8O | 1416775-08-0 | Details |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid | C25H23NO4 | 211637-75-1 | Details |
Fmoc-Lys(Mtt)-OH | C41H40N2O4 | 167393-62-6 | Details |
Lidorestat | C18H11F3N2O2S | 245116-90-9 | Details |
ALK inhibitor 1 | C23H28BrN7O3S | 761436-81-1 | Details |
AZD-3463 | C24H25ClN6O | 1356962-20-3 | Details |
Caficrestat | C17H10F3N5O3S | 1355612-71-3 | Details |
MS4077 | C55H72ClN9O13S | 2230077-10-6 | Details |
(S)-2-amino-3-(4-benzoylphenyl)propanoic acid | C16H15NO3 | 104504-45-2 | Details |
UNC5293 | C30H42N6O2 | 2226789-82-6 | Details |
Zopolrestat | C19H12F3N3O3S | 110703-94-1 | Details |
O-(tert-Butyl)-N-Fmoc-L-allothreonine | C23H27NO5 | 201481-37-0 | Details |
Uprosertib | C18H16Cl2F2N4O2 | 1047634-65-0 | Details |
Brigatinib | C29H39ClN7O2P | 1197953-54-0 | Details |
Boc-Ala-NMe(OMe) | C10H20N2O4 | 87694-49-3 | Details |
MS4078 | C45H52ClN9O8S | 2229036-62-6 | Details |
Azido-PEG4-Val-Cit-PAB-MMAE | C69H113N13O17 | 1869126-64-6 | Details |
ALM301 | C25H25N3O3 | 1313439-71-2 | Details |
PI3K/Akt/CREB activator 1 | C19H15F4NO3 | 2708177-73-3 | Details |
Boc-L-Tyrosine methyl ester | C15H21NO5 | 4326-36-7 | Details |
A-674563 | C22H22N4O | 552325-73-2 | Details |
Ipatasertib | C24H32ClN5O2 | 1001264-89-6 | Details |
Fmoc-Lys(Alloc)-OH | C25H28N2O6 | 146982-27-6 | Details |
TASP0415914 | C13H17N5O3S | 1292300-75-4 | Details |
R-268712 | C20H18FN5O | 879487-87-3 | Details |
ALK kinase inhibitor-1 | C28H32FN5O3S | 1462949-64-9 | Details |
Fmoc-D-Phe(4-F)-OH | C24H20FNO4 | 177966-64-2 | Details |
ALDH1A1-IN-2 | C25H23ClN4O3S | 2231081-18-6 | Details |
AKT-IN-3 | C23H23Cl2F2N5O3 | 2374740-21-1 | Details |
Sincalide ammonium | C49H65N11O16S3 | 70706-98-8 | Details |
Fmoc-Asp-OtBu | C23H25NO6 | 129460-09-9 | Details |
ITE | C14H10N2O3S | 448906-42-1 | Details |
ZX-29 | C23H28ClN7O3S | 2254805-62-2 | Details |
(E)-Akt inhibitor-IV | C31H27IN4S | 959841-49-7 | Details |
Fidarestat | C12H10FN3O4 | 136087-85-9 | Details |
XST-14 | C16H21NO4 | 2607143-50-8 | Details |
Akt1/Akt2-IN-1 | C33H29N7O | 893422-47-4 | Details |
ASP3026 | C29H40N8O3S | 1097917-15-1 | Details |
N-((Benzyloxy)carbonyl)-O-(tert-butyl)-L-threonine | C16H23NO5 | 16966-09-9 | Details |
Miransertib | C27H24N6 | 1313881-70-7 | Details |
LRE1 | C12H13ClN4S | 1252362-53-0 | Details |
N-Formyl-L-leucine | C7H13NO3 | 6113-61-7 | Details |
AMPD2 inhibitor 1 | C25H22N2O2 | 2139356-35-5 | Details |
Polatuzumab | 2279068-37-8 | Details |
Imirestat | C15H8F2N2O2 | 89391-50-4 | Details |
NCT-501 | C21H32N6O3 | 1802088-50-1 | Details |
BAY1125976 | C23H21N5O | 1402608-02-9 | Details |
NCT-506 | C25H23FN4O3S | 2231098-99-8 | Details |
Sorbinil | C11H9FN2O3 | 68367-52-2 | Details |
H-Phg(4-Cl)-OH | C8H8ClNO2 | 67336-19-0 | Details |
Fmoc-Phe(3,4-DiF)-OH | C24H19F2NO4 | 198560-43-9 | Details |
MKC-1 | C22H16N4O4 | 125313-92-0 | Details |
HG-14-10-04 | C29H34ClN7O | 1356962-34-9 | Details |
K-80003 | C22H21FO2 | 1292821-90-9 | Details |
Repotrectinib | C18H18FN5O2 | 1802220-02-5 | Details |
ABT 702 dihydrochloride | C22H19N6OBr.2HCl | 1188890-28-9 | Details |
Fmoc-Gly(allyl)-OH | C20H19NO4 | 146549-21-5 | Details |
Glembatumumab | 1020264-78-1 | Details |
Crosstide | C48H77N17O17 | 171783-05-4 | Details |
TDI-10229 | C16H16ClN5 | 2810887-45-5 | Details |
Fmoc-L-Lys(Dde)-OH | C31H36N2O6 | 150629-67-7 | Details |
N-Fmoc-O-benzyl-L-tyrosine | C31H27NO5 | 71989-40-7 | Details |
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(furan-2-yl)propanoic acid | C22H19NO5 | 220497-85-8 | Details |
COG 133 | C97H181N37O19 | 514200-66-9 | Details |
2-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoic acid | C12H15FN2O3 | 1289942-66-0 | Details |
(S)-methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate | C32H44N4O6 | 1140908-89-9 | Details |
Entrectinib | C31H34F2N6O2 | 1108743-60-7 | Details |
tert-Butyl 2-aminoacetate | C6H13NO2 | 6456-74-2 | Details |
AT-007 | C17H10F3N3O3S2 | 2170729-29-8 | Details |
TIP 39, Tuberoinfundibular Neuropeptide | C202H325N61O54S | 277302-47-3 | Details |
Lysipressin acetate | C48H69N13O14S2 | 83968-49-4 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 |